About MedX Health
MedX Health Corp, is listed on the Toronto TSX Venture Exchange (‘TSXV:MDX’).
Proudly Canadian, MedX develops and produces data-accurate decisions to online clinicians assessing skin with the world’s first FDA-approved Teledermatology platform. The MedX platform allows rapid, non-invasive imaging of skin lesions, which are securely transmitted to dermatologists for assessment within a period of 72 hours or less. Our technology is used by the lab technicians in the major Clinical Research Organisations in the world. MedX Photobiomodulation Lasers (Class III Cold Lasers) are known for their effectiveness, reliability and durability across the globe.
We Exist To Save Lives.
Our Executive team is led John Gevisser (CEO), Mike Druhan (President) and Meghan Geary (SVP-Operations). Executive Medical Board is headed by Dr. Trevor Champagne (Canada) and includes Dr. Paul Cohen (Canada) and Dr. Dan Siegel (USA).
Average wait time to see Dermatologists in:
What Our Clients Say
With MedX's optimised referral system, our highly accurate assessments and complete patient pathway has a proven catch rate of ~11% suspicious moles in 72hours or less.
Join the 200,000+ images already transforming care with MedX. Discover how our platform and patient pathways can deliver peace of mind to the worried well and escalations for those with suspicious lesions.
Get in touch today to see MedX in action.